Nothing here is for completeness. Each row changes an action.
🆕 The Kuhlman draw (L2605010156, 23 tests) is STILL PENDING as of 8/24 ⟨N 8-24⟩. Every rev since 7.44 wrote "~8/21". That was a forecast, not a document, and it did not happen. Nate's own framing: "in the next week or so, as I'm able" — coupled with the fecal elastase kit, one trip. There is no scheduled date and this page no longer prints one.
⚠️ This is the same failure class as the 8/7 → 8/10 correction, caught earlier. A forecast date carried across revs as though it were a fact. Surviving "~8/21" references elsewhere are historical forecasts, left as written — do not read them as scheduled, and do not bulk-replace them. 🔴 Everything gated on "after the ~8/21 draw" is now gated on "after the draw, date unset" — most consequentially the resveratrol cut, still queued and NOT executed ⟨N 8-24⟩, and the 48-hour iron skip before it.
🔴 And the panel now does two extra jobs it was not designed for: its glucose endpoints (fructosamine, insulin, HOMA-IR, C-peptide, HbA1c) will be an on-Cordyceps reading, and its CBC is now the substitute bleeding monitor for an antiplatelet-adjacent addition. See open items 69, 70.
Ferritin 10 (L) · Iron Saturation 4% — ALERT · Iron 16 (L) · TIBC 424 · UIBC 408 (H) · CRP 2 (normal) · Hgb 9.9 (L) (was 7.9 on 7/3) · Hct 32.3 (L) · MCV 82 · MCH 25.2 (L) · MCHC 30.7 (L) · RDW 14.4.
CRP normal is the finding that closes open item 3. This page spent four revs on the acute-phase trap — ferritin is an acute-phase reactant, Nate is ~8 weeks post-op, and Ret-He was named as the inflammation-independent test that was never ordered. With CRP at 2 there is nothing to adjust for. Ferritin 10 reads at face value. The ~8/21 sTfR, explicit TSAT and reticulocyte count are now confirmatory, not decisive — worth having as a paired series, but do not delay treatment for them.
Ganzoni deficit at 78.5 kg, Hgb 9.9: 78.5 × (14.0 − 9.9) × 2.4 = 772 mg, + 500 mg stores = ~1,272 mg. Oral at 36 mg elemental alternate-day closes that in roughly 8 months. One 1,000 mg ferric carboxymaltose infusion covers it in 15 minutes, and AASM gives IV FCM a strong recommendation at ferritin under 100 — this is 10, with TSAT 4%. ✅ CLOSED 8/27 — the route is IV and it went to KUHLMAN, not Wancata (open item 59). Referral placed for ferric derisomaltose (Monoferric), with ferric carboxymaltose specifically to be avoided. PHOSPHARE-IDA: hypophosphataemia 75.0% on FCM vs 7.9% on FDI, FGF23-driven and FCM-specific. ⚠ The AASM strong recommendation above is FCM's — do not read it as transferring to FDI (open item 80).
📌 Draw date corrected: every rev from 7.43 wrote 8/7. The Labcorp report reads Date collected: 08/10/2026 1113. 8/7 was the booking date, carried forward across five revs and never checked against a document. ⚠ HbA1c 5.6 is uninterpretable — post-transfusion pushes it down, iron deficiency pushes it up. CA 19-9 52, down from 73.6 on 1/20 — trajectory is the index. Albumin 4.4, up from 3.0, confirms that was a bleed artifact.
| What | Changes what | |
|---|---|---|
| 02 | PT / INR from the 6/29–7/3 admission (a records pull, not a new draw) | If prolonged: EPI-mediated vitamin K deficiency contributed to the bleed. Structural, fixable, retires the antiplatelet conversation. |
| 03 | Iron — 🟢 SUBSTANTIALLY COVERED across both orders. ✅ 8/7: ferritin · Iron/TIBC · CRP · B12 · folate · CBC. ✅ ~8/21 adds Soluble Transferrin Receptor · Reticulocyte Count · explicit TSAT · Methylmalonic Acid plus repeats of all the 8/7 iron tests. ❌ Still not ordered: Ret-He (CHr) · peripheral smear — but sTfR against log-ferritin handles the acute-phase confound Ret-He was wanted for. | IV vs oral iron · R-ALA gate · masked mixed deficiency (MCV 91 is suspiciously normal in a bleeding, iron-deficient EPI patient) |
| 04 | Sodium: serum osm · urine osm · urine Na · urine urea · uric acid · 8 AM cortisol · TSH | SIADH vs hypovolemia vs reset osmostat vs adrenal insufficiency. Gates the ARB. |
| 05 | Free water intake — three days, logged | If the hyponatremia is dilutional, the intervention is fluid restriction, not more salt. |
| 06 | Dietary protein — three days, weighed | ESPEN post-major-surgery 1.5–2.0 g/kg/day → 118–157 g/day at 78.5 kg ⟨i: imported population, not a target adopted⟩. 🔴 Amino-9 and HMB were both CUT 8/14, so there is no supplemental buffer at all now. ❌ “Largest untouched lever” struck 8/3 — C-origin editorial ranking, never a finding. ⚠ Prior text computed this on the retired ~75 kg weight. |
| 07 | rs10830963 (MTNR1B) — AncestryDNA raw file | Melatonin 1 mg vs 3 mg. Free. Ten minutes. |
| Orthostatic vitals | Supine → 1 min → 3 min standing | Volume status. The one finding you cannot self-generate. Critical before any ARB change. |
| 24-hour ABPM | Ambulatory monitor | Characterises the postprandial pattern. Must precede any berberine restart. |
| Supervised oral water load | Nephrology | Only if the panel points to the SIADH family. >80% excreted in 4 h = reset osmostat. <80% = SIADH. Not a home experiment. |
Rebuilt 8/14 from Wancata’s signed order set, 7/29/2026 — 22 orders, IDs 5033178020–041, contiguous, no gaps, all dx K86.1, all Release to patient: Immediate. 🔵 Updated 8/14: a SECOND order exists — Kuhlman, Labcorp L2605010156, 23 tests, draw ~8/21, not yet done. It closes six of the eight gaps below. 11 tests sit on both orders, which makes a paired ~2-week series rather than duplication waste. Results route to the ordering provider: 8/7 → Wancata (206-341-0060); ~8/21 → Kuhlman via Labcorp. ✅ Kuhlman is the PCP ⟨N✓8-17⟩ and holds 23 pending tests — results route to him and that is correct routing, not a collision. The "sequence the transition around that" warning is STRUCK: he has not been replaced. See pcp-vacancy.
| ✅ ORDERED (22) | CBC w/ diff · CMP (fasted) · Magnesium · Phosphorus · HbA1c · CA 19-9 · C-Peptide · Lipase · B12 · Folate ×2 · Vitamin A · D 25-OH · E · K · TSH · Pancreatic Elastase Fecal · Copper · Ceruloplasmin · Iron and TIBC · Ferritin · CRP |
⚠ Advanced Lipid 260267 — Kuhlman | 🔵 ORDERED after all, on the ~8/21 draw. 🔴 Whether it includes ApoB and Lp(a) is UNCONFIRMED — one search did not resolve the code, and Berberine’s gate and the mastic reach both name those specifically. Open item 51. |
✅ Albumin/Creatinine Ratio, Urine 140285 — Kuhlman | 🔵 CLOSED 8/14 — it IS being measured, on the ~8/21 draw. The only remaining axis that could justify telmisartan 80 gets its reading. The BP re-baseline quoted here (120.8/66.5) is itself superseded: current protocol-correct mornings run 119.5–133.5 systolic, 28-day mean 126/66. |
✅ Prealbumin 016931 · ✅ Zinc 001800 — Kuhlman | 🔵 BOTH CLOSED 8/14 on the ~8/21 draw. Zn:Cu is answerable. ⚠ But there is no PRE-CUT prealbumin and there cannot be — both EAA sources came out 8/14, prealbumin has a ~2-day half-life, and the draw is a week later. It reads post-cut status, not a before-and-after. |
| Serum copper + ceruloplasmin new 7.19 | Copper is the DAO metal cofactor and currently unmeasured. ⚠ Ceruloplasmin is acute-phase — read only against the CRP already on this panel, same trap as ferritin, or the number is uninterpretable. |
| ✅ 25-OH-D · Ca (on CMP) | 🆕 D3 total is now 7,000 IU — the ~1,000 IU HMB bundle left with the 8/14 cut. ⚠ This draw was taken with the bundle still on board (~8,000 IU D3, ~398 mg supplemental Ca), so it is an on-HMB reading and will not compare to anything measured after 8/14. |
| ✅ Vitamin A · E · K | 🆕 Fat-soluble panel — appropriate for exocrine insufficiency and absent from this hub until 8/14. All on-supplement readings (Vit E 200 IU, K2 180 µg/day). Vitamin K is the pending half of the bleed question in row 02. |
| ✅ Pancreatic Elastase Fecal | 🔴 The only direct measure of exocrine function in the set — the one test that speaks to Creon dosing. It is a STOOL test. If 8/7 was phlebotomy only, it may never have been collected. |
✅ Fructosamine 100800 — Kuhlman | 🔵 CLOSED 8/14 on the ~8/21 draw. The instrument this hub called the only trustworthy glycemic read until the CGM is validated. HbA1c (Wancata, 8/7) still carries its transfusion caveat below. |
✅ C-Peptide (both) · ✅ Insulin 004333 — Kuhlman | 🔵 CLOSED 8/14 — HOMA-IR is computable from the ~8/21 insulin + CMP glucose. The agmatine/gymnema hold had a real endpoint after all. ⚠ C-peptide is on both orders, so you get it twice, two weeks apart — which is better than the single fasting value this hub warned against adjudicating on. |
| HbA1c — 🆕 ORDERED ANYWAY | drawn ~5 wks post-transfusion | ⚠ The deferral reason still holds: falsely low this soon after 2u RBC. The result is coming and should not be read as a clean glycemic index. |
| CA 19-9 — 🆕 ORDERED ANYWAY | drawn ~6 wks post-Frey | ⚠ Prior 73.6 (H), 1/20/2026; 6/18 pathology benign. CA 19-9 has poor specificity in chronic pancreatitis and biliary disease — an elevated value is not by itself a cancer finding. A trajectory is the index, not a single value. Interpretation is Wancata’s. CEA was not ordered. |
📌 8/3 — retired, argument and all. Its own reconciliation line always said it: the team attributed the ulcers to non-specific post-op change and ran no etiology hunt — a low-cost hedge, not a live alarm. The header calling it "the load-bearing unknown" is what propagated, into the MegaSpore gate, a PPI-washout item, a mastic-gum flag, and an 8/3 NAC "test confound" that is now retracted. No positive finding ever existed. Nothing waits on this.
Ferritin is an acute-phase reactant and you are ~4 weeks post-major surgery. Ret-He / CHr is the test — inflammation-independent, reports iron incorporated into hemoglobin over 48 hours. ⚠ It was not ordered on either draw — but Kuhlman ordered Soluble Transferrin Receptor, the other inflammation-independent marker, with the larger validation literature. sTfR against log-ferritin is the established way to separate true iron deficiency from anemia of chronic disease. 🛑 No add-on call is needed. If IV iron is indicated, ask for ferric derisomaltose (Monoferric) by name — not ferric carboxymaltose (formulation-specific hypophosphatemia).